FI943067A0 - Mikrokapselien valmistusmenetelmä - Google Patents

Mikrokapselien valmistusmenetelmä

Info

Publication number: FI943067A0
Authority: FI; Finland
Prior art keywords: microcapsules; manufacturing microcapsules; solvents; biodegradable; vaccines
Prior art date: 1992-10-26

Application number

FI943067A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI943067L (fi

Inventor

Bruno Gander

Hans Peter Merkle

Original Assignee

Sanol Arznei Schwarz Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-26

Filing date

1994-06-23

Publication date

1994-06-23

1994-06-23 Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh

1994-06-23 Publication of FI943067L publication Critical patent/FI943067L/fi

1994-06-23 Publication of FI943067A0 publication Critical patent/FI943067A0/fi

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
- B01J13/043—Drying and spraying
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Manufacturing Of Micro-Capsules (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI943067A 1992-10-26 1994-06-23 Mikrokapselien valmistusmenetelmä FI943067A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH331992		1992-10-26
PCT/CH1993/000246 WO1994009898A1 (de)	1992-10-26	1993-10-18	Verfahren zur herstellung von mikrokapseln

Publications (2)

Publication Number	Publication Date
FI943067L FI943067L (fi)	1994-06-23
FI943067A0 true FI943067A0 (fi)	1994-06-23

Family

ID=4253421

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI943067A FI943067A0 (fi)	1992-10-26	1994-06-23	Mikrokapselien valmistusmenetelmä

Country Status (14)

Country	Link
US (1)	US5648096A (hu)
EP (1)	EP0625069B1 (hu)
JP (1)	JP3523254B2 (hu)
KR (1)	KR100225983B1 (hu)
CN (1)	CN1058864C (hu)
AT (1)	ATE175132T1 (hu)
CA (1)	CA2126685C (hu)
DE (1)	DE59309257D1 (hu)
DK (1)	DK0625069T3 (hu)
ES (1)	ES2127835T3 (hu)
FI (1)	FI943067A0 (hu)
GR (1)	GR3029504T3 (hu)
HU (1)	HU221308B1 (hu)
WO (1)	WO1994009898A1 (hu)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5693343A (en)	1984-03-16	1997-12-02	The United States Of America As Represented By The Secretary Of The Army	Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
US20030161889A1 (en) *	1984-03-16	2003-08-28	Reid Robert H.	Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
US6410056B1 (en)	1984-03-16	2002-06-25	The United States Of America As Represented By The Secretary Of The Army	Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
US6309669B1 (en)	1984-03-16	2001-10-30	The United States Of America As Represented By The Secretary Of The Army	Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
USRE40786E1 (en)	1984-03-16	2009-06-23	The United States Of America As Represented By The Secretary Of The Army	Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
US6217911B1 (en)	1995-05-22	2001-04-17	The United States Of America As Represented By The Secretary Of The Army	sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
WO1992019263A1 (en)	1991-04-24	1992-11-12	The United States Of America, As Represented By The Secretary Of The Army	Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
KR100291357B1 (ko) *	1993-01-08	2001-09-17	터베이 피터.	백신제제
US6939546B2 (en)	1993-05-21	2005-09-06	The United States Of America As Represented By The Secretary Of The Army	Model for testing immunogenicity of peptides
US6051256A (en) *	1994-03-07	2000-04-18	Inhale Therapeutic Systems	Dispersible macromolecule compositions and methods for their preparation and use
US6855331B2 (en)	1994-05-16	2005-02-15	The United States Of America As Represented By The Secretary Of The Army	Sustained release hydrophobic bioactive PLGA microspheres
US6447796B1 (en)	1994-05-16	2002-09-10	The United States Of America As Represented By The Secretary Of The Army	Sustained release hydrophobic bioactive PLGA microspheres
GB9420355D0 (en) *	1994-10-10	1994-11-23	Univ Nottingham	Preparation of protein microspheres, films and coatings
GB9423419D0 (en) *	1994-11-19	1995-01-11	Andaris Ltd	Preparation of hollow microcapsules
US6333021B1 (en) *	1994-11-22	2001-12-25	Bracco Research S.A.	Microcapsules, method of making and their use
US6902743B1 (en) *	1995-05-22	2005-06-07	The United States Of America As Represented By The Secretary Of The Army	Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
US7033608B1 (en)	1995-05-22	2006-04-25	The United States Of America As Represented By The Secretary Of The Army	“Burst-free” sustained release poly-(lactide/glycolide) microspheres
EP0862420A4 (en) *	1995-10-13	1999-11-03	Penn State Res Found	SYNTHESIS OF DRUG SPRAY DRUG NANOPARTICLES
US6270795B1 (en)	1995-11-09	2001-08-07	Microbiological Research Authority	Method of making microencapsulated DNA for vaccination and gene therapy
JP2000500744A (ja)	1995-11-09	2000-01-25	マイクロバイオロジカルリサーチオーソリティー	ワクチン接種および遺伝子治療のためのマイクロカプセル化ｄｎａ
DE19545257A1 (de)	1995-11-24	1997-06-19	Schering Ag	Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US5980945A (en) *	1996-01-16	1999-11-09	Societe De Conseils De Recherches Et D'applications Scientifique S.A.	Sustained release drug formulations
FR2757510B1 (fr) *	1996-12-23	2000-01-07	Sanofi Sa	Forme microparticulaire d'un derive de tetrahydropyridine
US20030203036A1 (en) *	2000-03-17	2003-10-30	Gordon Marc S.	Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
US5985248A (en)	1996-12-31	1999-11-16	Inhale Therapeutic Systems	Processes for spray drying solutions of hydrophobic drugs and compositions thereof
US20020182258A1 (en) *	1997-01-22	2002-12-05	Zycos Inc., A Delaware Corporation	Microparticles for delivery of nucleic acid
US5783567A (en) *	1997-01-22	1998-07-21	Pangaea Pharmaceuticals, Inc.	Microparticles for delivery of nucleic acid
US6126919A (en)	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
US20050171408A1 (en) *	1997-07-02	2005-08-04	Parker Jeffery R.	Light delivery systems and applications thereof
DE69722610T2 (de) *	1997-08-08	2004-04-29	Rotta Research Laboratorium S.P.A., Monza	Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
US6716823B1 (en)	1997-08-13	2004-04-06	The Uab Research Foundation	Noninvasive genetic immunization, expression products therefrom, and uses thereof
US20030045492A1 (en) *	1997-08-13	2003-03-06	Tang De-Chu C.	Vaccination by topical application of recombinant vectors
US6348450B1 (en)	1997-08-13	2002-02-19	The Uab Research Foundation	Noninvasive genetic immunization, expression products therefrom and uses thereof
US20030125278A1 (en) *	1997-08-13	2003-07-03	Tang De-Chu C.	Immunization of animals by topical applications of a salmonella-based vector
UA65607C2 (uk)	1998-03-04	2004-04-15	Орто-Макнейл Фармацевтикал, Інк.	Фармацевтична композиція (варіанти) та спосіб її приготування
AU744354B2 (en)	1998-03-20	2002-02-21	Takeda Chemical Industries Ltd.	Sustained-release preparation of physiologically active polypeptide and production thereof
GB9810236D0 (en)	1998-05-13	1998-07-08	Microbiological Res Authority	Improvements relating to encapsulation of bioactive agents
US6406719B1 (en)	1998-05-13	2002-06-18	Microbiological Research Authority	Encapsulation of bioactive agents
AU4697099A (en)	1998-06-18	2000-01-05	Johns Hopkins University School Of Medicine, The	Polymers for delivery of nucleic acids
US7087236B1 (en)	1998-09-01	2006-08-08	Merrion Research I Limited	Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
US20040009936A1 (en) *	1999-05-03	2004-01-15	Tang De-Chu C.	Vaccine and drug delivery by topical application of vectors and vector extracts
US20050037086A1 (en) *	1999-11-19	2005-02-17	Zycos Inc., A Delaware Corporation	Continuous-flow method for preparing microparticles
US7732404B2 (en)	1999-12-30	2010-06-08	Dexcel Ltd	Pro-nanodispersion for the delivery of cyclosporin
WO2001093835A1 (en) *	2000-06-02	2001-12-13	Zycos Inc.	Delivery systems for bioactive agents
US7575761B2 (en)	2000-06-30	2009-08-18	Novartis Pharma Ag	Spray drying process control of drying kinetics
WO2002009669A2 (en) *	2000-08-01	2002-02-07	Inhale Therapeutic Systems, Inc.	Apparatus and process to produce particles having a narrow size distribution and particles made thereby
US7666445B2 (en) *	2000-10-20	2010-02-23	The Trustees Of The University Of Pennsylvania	Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
DE10055857A1 (de) *	2000-11-10	2002-08-22	Creative Peptides Sweden Ab Dj	Neue pharmazeutische Depotformulierung
US7749539B2 (en) *	2000-11-30	2010-07-06	Efrat Biopolymers Ltd.	Polymeric formulations for drug delivery
US6899898B2 (en)	2000-12-21	2005-05-31	Nektar Therapeutics	Induced phase transition method for the production of microparticles containing hydrophobic active agents
US20030032675A1 (en) *	2001-02-15	2003-02-13	Franz G. Andrew	Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030224047A1 (en) *	2001-02-15	2003-12-04	Franz G. Andrew	Levothyroxine compositions and methods
EP1365745A2 (en) *	2001-02-15	2003-12-03	King Pharmaceuticals, Inc.	Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
US20030198671A1 (en) *	2001-08-10	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique plasma AUC properties
US20030190349A1 (en) *	2001-08-10	2003-10-09	Franz G. Andrew	Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) *	2001-08-10	2003-10-23	Franz Andrew G.	Methods of producing dispersible pharmaceutical compositions
US20030180353A1 (en) *	2001-08-10	2003-09-25	Franz G. Andrew	Stabilized pharmaceutical compositions
US20030195253A1 (en) *	2001-08-14	2003-10-16	Franz G. Andrew	Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
US20030199586A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Unique levothyroxine aqueous materials
US20030198672A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030203967A1 (en) *	2001-08-14	2003-10-30	Franz G. Andrew	Levothyroxine compositions having unique Tmax properties
US20030199587A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique Cmax properties
US7098305B2 (en) *	2001-09-06	2006-08-29	Ardana Bioscience Limited	Sustained release of microcrystalline peptide suspensions
US20030171436A1 (en) *	2001-10-29	2003-09-11	Franz G. Andrew	Levothyroxine compositions having unique triiodothyronine Tmax properties
EP1992335A1 (en) *	2001-11-01	2008-11-19	Nektar Therapeutics	Spray drying methods and compositions thereof
US20040142902A1 (en) *	2001-11-08	2004-07-22	Struijker- Boudier Harry A.J.	Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
US8128957B1 (en) *	2002-02-21	2012-03-06	Valeant International (Barbados) Srl	Modified release compositions of at least one form of tramadol
US20050182056A9 (en) *	2002-02-21	2005-08-18	Seth Pawan	Modified release formulations of at least one form of tramadol
GB0216562D0 (en)	2002-04-25	2002-08-28	Bradford Particle Design Ltd	Particulate materials
US9339459B2 (en)	2003-04-24	2016-05-17	Nektar Therapeutics	Particulate materials
WO2004035028A1 (fr) *	2002-10-17	2004-04-29	Gosudarstvenny Nauchny Tsentr Virusologii I Biotekhnologii 'vektor'	Procede de production d'une forme microencapsulee d'un vaccin viral vivant
AU2003302329B2 (en) *	2002-12-30	2010-01-07	Novartis Ag	Prefilming atomizer
KR20060015316A (ko) *	2003-05-28	2006-02-16	넥타르 테라퓨틱스	아미노산 및/또는 인지질로 부분 또는 완전 코팅된수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의분무 건조법
BRPI0318456B8 (pt) *	2003-08-08	2021-05-25	Biovail Laboratories Int Srl	tablete com liberação modificada
US20050037047A1 (en) *	2003-08-11	2005-02-17	Young-Ho Song	Medical devices comprising spray dried microparticles
WO2005070332A1 (en) *	2004-01-12	2005-08-04	The Trustees Of The University Of Pennsylvania	Long-term delivery formulations and methods of use thereof
US8221778B2 (en)	2005-01-12	2012-07-17	The Trustees Of The University Of Pennsylvania	Drug-containing implants and methods of use thereof
BRPI0511807C8 (pt) *	2004-06-04	2021-05-25	Camurus Ab	pré-formulação, processo de formação de uma pré-formulação e uso da mesma
JP2008531581A (ja) *	2005-02-23	2008-08-14	ユーエービーリサーチファウンデーション	アルキル−グリコシドで増強されたワクチン接種
EP1896002A4 (en) *	2005-06-27	2009-11-25	Biovail Lab Int Srl	BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
WO2007014445A1 (en) *	2005-08-02	2007-02-08	Miv Therapeutics Inc.	Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
US20070286814A1 (en) *	2006-06-12	2007-12-13	Medispray Laboratories Pvt. Ltd.	Stable aerosol pharmaceutical formulations
CN101239296B (zh) *	2008-03-07	2010-04-21	清华大学	一种制备溶剂微胶囊的方法
CN101543757B (zh) *	2009-04-30	2011-05-04	上海交通大学	利用声表面波雾化器实现芯材微胶囊化的制备方法
WO2012009973A1 (zh) *	2010-07-20	2012-01-26	上海交通大学医学院附属新华医院	一种含有抗帕金森病药物的微球组合药物及其应用
US10087401B2 (en)	2012-03-16	2018-10-02	Monosol, Llc	Water soluble compositions incorporating enzymes, and method of making same
US9394092B2 (en)	2012-04-16	2016-07-19	Monosol, Llc	Powdered pouch and method of making same
CN102698664B (zh) *	2012-05-26	2014-03-12	云南恩典科技产业发展有限公司	一种包水微胶囊的制备方法
SI2877155T1 (sl)	2012-07-26	2021-04-30	Camurus Ab	Opioidne formulacije
EA034855B1 (ru)	2012-07-26	2020-03-30	Камурус Аб	Предшественник депо-препарата, содержащий бупренорфин, и способ лечения путем его введения
CN103506058B (zh) *	2013-10-09	2015-05-13	上海理工大学	微胶囊喷雾干燥装置
WO2016054528A2 (en)	2014-10-03	2016-04-07	Monosol, Llc	Degradable materials and packaging made from same
WO2016097848A1 (en)	2014-12-18	2016-06-23	Dexcel Pharma Technologies Ltd.	Alternating and semi-alternating poly(ester-anhydride) copolymers
AU2017406466A1 (en)	2017-03-29	2019-10-17	Dexcel Pharma Technologies Ltd.	Compositions comprising biodegradable copolymers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4637905A (en) *	1982-03-04	1987-01-20	Batelle Development Corporation	Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or ε-caprolactones
US4530840A (en) *	1982-07-29	1985-07-23	The Stolle Research And Development Corporation	Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
JPS6067417A (ja) *	1983-09-24	1985-04-17	Tetsuo Kato	生体内代謝性マイクロカプセルの製法
IE58110B1 (en) *	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
DE3738228A1 (de) *	1987-11-11	1989-05-24	Hoechst Ag	Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
JP2670680B2 (ja) *	1988-02-24	1997-10-29	株式会社ビーエムジー	生理活性物質含有ポリ乳酸系微小球およびその製造法
ES2051968T3 (es) *	1988-12-22	1994-07-01	American Cyanamid Co	Metodo para el tratamiento de enfermedad periodontal mediante la liberacion continua de un agente terapeutico a la bolsa periodontal; composicion de materia del mismo y aparato para su administracion.
IL92344A0 (en) *	1989-01-04	1990-07-26	Gist Brocades Nv	Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
JPH04247987A (ja) *	1991-01-18	1992-09-03	Fuji Photo Film Co Ltd	感熱記録材料
YU48420B (sh) *	1991-03-25	1998-07-10	Hoechst Aktiengesellschaft	Postupak za dobijanje biološki razgradljivih mikročestica sa dugotrajnim delovanjem

1993
- 1993-10-18 DE DE59309257T patent/DE59309257D1/de not_active Expired - Fee Related
- 1993-10-18 EP EP93922486A patent/EP0625069B1/de not_active Expired - Lifetime
- 1993-10-18 ES ES93922486T patent/ES2127835T3/es not_active Expired - Lifetime
- 1993-10-18 HU HU9401329A patent/HU221308B1/hu not_active IP Right Cessation
- 1993-10-18 AT AT93922486T patent/ATE175132T1/de not_active IP Right Cessation
- 1993-10-18 WO PCT/CH1993/000246 patent/WO1994009898A1/de active IP Right Grant
- 1993-10-18 CA CA002126685A patent/CA2126685C/en not_active Expired - Fee Related
- 1993-10-18 DK DK93922486T patent/DK0625069T3/da active
- 1993-10-18 JP JP51051894A patent/JP3523254B2/ja not_active Expired - Fee Related
- 1993-10-18 KR KR1019940702042A patent/KR100225983B1/ko not_active Expired - Fee Related
- 1993-10-26 CN CN93119645A patent/CN1058864C/zh not_active Expired - Fee Related
1994
- 1994-06-22 US US08/264,007 patent/US5648096A/en not_active Expired - Fee Related
- 1994-06-23 FI FI943067A patent/FI943067A0/fi not_active IP Right Cessation
1999
- 1999-02-26 GR GR990400601T patent/GR3029504T3/el unknown

Also Published As

Publication number	Publication date
EP0625069B1 (de)	1998-12-30
CA2126685A1 (en)	1994-05-11
WO1994009898A1 (de)	1994-05-11
US5648096A (en)	1997-07-15
GR3029504T3 (en)	1999-05-28
JPH07502686A (ja)	1995-03-23
CN1090172A (zh)	1994-08-03
HU221308B1 (en)	2002-09-28
CA2126685C (en)	2002-07-23
KR940703713A (ko)	1994-12-12
JP3523254B2 (ja)	2004-04-26
CN1058864C (zh)	2000-11-29
FI943067L (fi)	1994-06-23
ATE175132T1 (de)	1999-01-15
EP0625069A1 (de)	1994-11-23
DE59309257D1 (de)	1999-02-11
DK0625069T3 (da)	1999-08-30
HUT70418A (en)	1995-10-30
ES2127835T3 (es)	1999-05-01
HU9401329D0 (en)	1994-08-29
KR100225983B1 (ko)	1999-10-15

Publication	Publication Date	Title
FI943067A0 (fi)	1994-06-23	Mikrokapselien valmistusmenetelmä
RU95114361A (ru)	1997-04-10	Липкие полимерные микросферы, способ получения водной суспензии микросфер, листовой материал, чувствительный к давлению клей, водная суспензия
MX9100249A (es)	1992-02-28	Sistema para suministrar medicamentos y proceso para preparar el mismo
DE69116144D1 (de)	1996-02-15	Bindung substratspezifischer affinitätssubstanzen an liposomen
NO961963L (no)	1996-05-14	Mikrokapsler som inneholder suspensjoner av biologisk aktive forbindelser
BR9405635A (pt)	1999-09-08	Sistema de segurança e processo de operação de sistema de segurança para proteger uma área
AU7361296A (en)	1997-04-09	Purified mannanase from bacillus amyloliquefaciens and method of preparation
DE69834741D1 (de)	2006-07-06	Cellulase aus actinomycetes und herstellungsverfahren dafür
DE69829308D1 (de)	2005-04-14	Cellulase aus actinomycetes und herstellungsverfahren dafür
FI960851A0 (fi)	1996-02-23	Menetelmä N-amino-1-hydroksi-alkylideeni-1,1-bisfosfonihappojen valmistamiseksi
ATE273320T1 (de)	2004-08-15	Fusogene liposomen
EP0387567A3 (en)	1991-01-02	Amphoteric polyelectrolyte, method for production thereof, and organic sludge dehydrater
FI930672A0 (fi)	1993-02-16	Foerfarande foer framstaellning av polymermikrokapslar som innehaoller biologiskt aktivt material
AU2503788A (en)	1989-05-25	Process for the production of biodegradable microcapsules of water-soluble peptides and proteins, and microcapsules obtained by this process
BR9301489A (pt)	1993-10-13	Processos para a preparacao de enzima purificada a partir de um caldo de fermentacao e para a preparacao de protease alcalina purificada derivada de bacillus alcalophilus ou bacillus lichenformis a partir de um caldo de fermentacao,uso de uma protease alcalina purificada e composicao solida e liquida
LV10304A (lv)	1994-10-20	Struktureti kristali ka jauna fermentu imobilizacijas forma
ES2137216T3 (es)	1999-12-16	Agentes de revestimiento acuosos y su uso para la produccion de revestimientos permeables al vapor de agua.
DE69311734D1 (de)	1997-07-24	Depolymerisation von nylon 66 (und gegebenenfalls nylon 6) zur herstellung von hexamethylendiamin (und caprolactam)
FI942843A0 (fi)	1994-06-15	Aminohappojen erotus, aminohappoperustainen monomeeri, ja menetelmä sen valmistamiseksi, sekä polymeerimateriaali ja menetelmä sen valmistamiseksi
SE9501285D0 (sv)	1995-04-06	a process for the production of biologically active proteins
AU7577496A (en)	1997-05-29	Membrane for chemical and biosensors
AU5256096A (en)	1996-10-30	Microencapsulation process
GB1532160A (en)	1978-11-15	Method of bondine biologically active proteins to inorganic support materials
NO20034547L (no)	2003-12-10	Mikrokapsler
ATE132160T1 (de)	1996-01-15	Verfahren zur reinigung von aussenmembran-protein von haemophilus influenza

Legal Events

Date	Code	Title	Description
2007-04-30	MA	Patent expired